Taming the Storm: Medical Control of Cortisol
At a Glance
In an ACTH-producing pancreatic neuroendocrine tumor, urgent cortisol control may come before tumor treatment. Medicines can lower cortisol or block its effects; severe cases may need ICU etomidate or bilateral adrenalectomy, followed by lifelong steroid replacement.
While the pancreatic tumor is the source of the problem, the hormone it produces—ACTH—is what is actively endangering your life. Depending on your condition, your team may prioritize treating the tumor directly, but in cases of severe ectopic Cushing syndrome, the immediate goal is often to “block” the production of cortisol to prevent life-threatening complications like sepsis, heart failure, or severe psychosis [1][2]. This process is known as medical blockade.
Why Blockade Comes First
Surgery for a pancreatic tumor is a major procedure. If your body is currently flooded with cortisol, your risk for dangerous infections, poor wound healing, and blood clots during surgery is extremely high [1][3]. By using medications to stabilize your hormone levels first, your team is “preparing” your body to safely undergo treatment for the tumor itself later [4][5].
Medications to Lower Cortisol
Your doctors use a class of drugs called steroidogenesis inhibitors. These work like chemical “brakes” that stop your adrenal glands from manufacturing cortisol [6]. Always take these exactly as directed and do not stop without medical guidance.
- Metyrapone & Osilodrostat: These drugs block an enzyme (11β-hydroxylase) essential for making cortisol [7]. Osilodrostat is highly potent; in studies of severe ectopic cases, some studies suggest rapid cortisol improvement, though results vary [8]. They can increase steroid precursors, potentially worsening hypertension or hypokalemia.
- Ketoconazole: Originally an antifungal, this drug is a powerful cortisol blocker used off-label. However, it requires careful monitoring because it can cause hepatotoxicity (liver injury) and dangerous drug interactions [9][10].
- Mifepristone: Unlike the others, this drug doesn’t lower the amount of cortisol in your blood. Instead, it is a receptor blocker—it sits on the “docking stations” of your cells so the cortisol cannot “plug in” and cause damage [11]. It can be helpful for some patients for rapidly improving high blood sugar and psychiatric symptoms, but it can also severely worsen hypokalemia and has important drug interactions [12]. Because it leaves measured blood cortisol levels high, doctors cannot use standard lab tests to judge its effect.
The ICU “Rescue”: Etomidate
If your cortisol levels are a critical emergency, or if you cannot take pills, your team may use etomidate [1]. This is an intravenous medication given in the Intensive Care Unit (ICU). It can lower cortisol levels by more than 50% within the first 24 hours, providing a rapid “bridge” to stabilize you [13][14].
Risks and Monitoring
The most significant risk of these medications is adrenal insufficiency (or “Addisonian crisis”)—where your cortisol levels drop too low [8]. Your team will monitor you for symptoms like:
- Sudden, extreme fatigue or weakness.
- Nausea and vomiting.
- Dizziness or a sharp drop in blood pressure.
Because some of these drugs can also affect the electrical rhythm of your heart, you may need periodic EKGs to monitor your “QT interval” [7].
The “Rescue” Surgery: Bilateral Adrenalectomy
If medications cannot control the hormone flood, your team may recommend a bilateral adrenalectomy—the surgical removal of both adrenal glands [1].
- Why it’s done: It is a definitive way to control adrenal cortisol production, though it does not cure the underlying ACTH-producing pancreatic tumor [15]. It instantly stops the production of cortisol.
- The Consequence: Because you will no longer have adrenal glands, your body will never produce cortisol again. You will require lifelong steroid replacement (usually hydrocortisone and fludrocortisone) [16]. You must take these every day to survive, similar to how a person with Type 1 diabetes requires insulin.
- Safety First: After this surgery, you must carry an emergency medical alert and learn “sick day rules” for increasing your steroid dose during times of illness or injury, as well as keeping emergency injectable hydrocortisone on hand [17].
Common questions in this guide
Why might cortisol be lowered before treating my pancreatic ACTH-producing tumor?
What medicines can control cortisol in ectopic Cushing syndrome?
How will my doctors know if cortisol-lowering treatment is working or becoming too strong?
What is bilateral adrenalectomy, and will it cure the pancreatic tumor?
What should I do if I become ill after bilateral adrenalectomy?
Get notified when new evidence is published on pancreatic ACTH-producing neuroendocrine tumor.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Therapeutic Strategies for the Treatment of Severe Cushing's Syndrome.
Alexandraki KI, Grossman AB
Drugs 2016; (76(4)):447-58 doi:10.1007/s40265-016-0539-6.
PMID: 26833215 - 2
Characteristics and outcomes of the Finnish ectopic ACTH syndrome cohort.
Toivanen S, Leijon H, Arola A, et al.
Endocrine 2021; (74(2)):387-395 doi:10.1007/s12020-021-02768-0.
PMID: 34036515 - 3
Adrenocorticotropic hormone-secreting pancreatic neuroendocrine carcinoma with multiple organ infections and widespread thrombosis: A case report.
Yoshihara A, Nishihama K, Inoue C, et al.
World journal of clinical cases 2022; (10(17)):5723-5731 doi:10.12998/wjcc.v10.i17.5723.
PMID: 35979125 - 4
MANAGEMENT OF ENDOCRINE DISEASE: Cushing's syndrome due to ectopic ACTH secretion: an expert operational opinion.
Young J, Haissaguerre M, Viera-Pinto O, et al.
European journal of endocrinology 2020; (182(4)):R29-R58.
PMID: 31999619 - 5
Update in the Management of ACTH-Secreting Gastroenteropancreatic and Thoracic Neuroendocrine Neoplasms.
Tsoli M, Bel-Ange A, Atlan K, et al.
Current treatment options in oncology 2025; (26(11)):1010-1022 doi:10.1007/s11864-025-01354-0.
PMID: 41042443 - 6
Update and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome.
Araujo-Castro M, Lamas C, Nowak E, et al.
Endocrine reviews 2026; (47(3)):301-328 doi:10.1210/endrev/bnaf042.
PMID: 41489578 - 7
Osilodrostat Treatment for Adrenal and Ectopic Cushing Syndrome: Integration of Clinical Studies With Case Presentations.
Fleseriu M, Auchus RJ, Bancos I, Biller BMK
Journal of the Endocrine Society 2025; (9(4)):bvaf027 doi:10.1210/jendso/bvaf027.
PMID: 40104565 - 8
Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France.
Dormoy A, Haissaguerre M, Vitellius G, et al.
The Journal of clinical endocrinology and metabolism 2023; (108(6)):1475-1487 doi:10.1210/clinem/dgac691.
PMID: 36470583 - 9
Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole.
Corcuff JB, Young J, Masquefa-Giraud P, et al.
European journal of endocrinology 2015; (172(4)):473-81 doi:10.1530/EJE-14-0913.
PMID: 25624013 - 10
Cushing Syndrome due to a Pancreatic Neuroendocrine Tumor Treated With Radiofrequency Ablation.
Gugger AS, Fang J, Visrodia KH, Page-Wilson G
JCEM case reports 2023; (1(2)):luad022 doi:10.1210/jcemcr/luad022.
PMID: 37908478 - 11
Mifepristone in the treatment of the ectopic adrenocorticotropic hormone syndrome.
Wannachalee T, Turcu AF, Auchus RJ
Clinical endocrinology 2018; (89(5)):570-576 doi:10.1111/cen.13818.
PMID: 30019523 - 12
Ectopic ACTH syndrome caused by thymic neuroendocrine tumor: a case report and literature review.
Pan J, Lin W, Zong L, et al.
Annals of palliative medicine 2022; (11(4)):1575-1581 doi:10.21037/apm-21-86.
PMID: 34263608 - 13
Etomidate in severe hypercortisolism: early cortisol kinetics and clinical outcomes in a real-world cohort.
Jha V, Bhadada T, Shaharyar A, et al.
Pituitary 2026; (29(4)).
PMID: 42384093 - 14
Is there still a place for etomidate in the management of Cushing's syndrome? The experience of a single center of low-dose etomidate and combined etomidate-osilodrostat treatment in severe hypercortisolemia.
Dzialach L, Sobolewska J, Respondek W, et al.
Endocrine 2025; (87(3)):1305-1313 doi:10.1007/s12020-024-04135-1.
PMID: 39694989 - 15
Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome.
Landry JP, Clemente-Gutierrez U, Pieterman CRC, et al.
Surgery 2022; (172(2)):559-566 doi:10.1016/j.surg.2022.03.014.
PMID: 35437162 - 16
Cyclical ectopic Cushing's syndrome due to a mediastinal neuroendocrine tumor: a case-based review.
Peixe C, Lopes MV, de Griné Severino M, et al.
Irish journal of medical science 2026; doi:10.1007/s11845-026-04432-w.
PMID: 42126756 - 17
Differences in morbidity and mortality between unilateral adrenalectomy for adrenal Cushing's syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal Cushing's syndrome.
Reibetanz J, Kelm M, Uttinger KL, et al.
Langenbeck's archives of surgery 2022; (407(6)):2481-2488 doi:10.1007/s00423-022-02568-8.
PMID: 35633419
This page is for informational purposes only and does not constitute medical advice. Cortisol-lowering medicines and adrenalectomy require individualized supervision by your endocrinology and oncology team.